日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

一项评估使用 Uproleselan 抑制 E-选择素以降低多发性骨髓瘤自体造血干细胞移植期间胃肠道毒性的 II 期随机、双盲、安慰剂对照试验

Crees, Zachary D; Stockerl-Goldstein, Keith; Ryan, Meaghan; Gao, Feng; Christen, Brandon; Mayeski, Chris; Slade, Michael J; Schroeder, Mark A; Vij, Ravi; DiPersio, John F; Uy, Geoffrey L

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation

伊他替尼用于预防单倍体移植中的移植物抗宿主病和细胞因子释放综合征

Abboud, Ramzi; Schroeder, Mark A; Rettig, Michael P; Jayasinghe, Reyka G; Gao, Feng; Eisele, Jeremy; Gehrs, Leah; Ritchey, Julie; Choi, Jaebok; Abboud, Camille N; Pusic, Iskra; Jacoby, Meagan; Westervelt, Peter; Christopher, Matthew; Cashen, Amanda; Ghobadi, Armin; Stockerl-Goldstein, Keith; Uy, Geoffrey L; DiPersio, John F

Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell Dyscrasias

便利性与连续性:浆细胞疾病患者转诊至卫星诊所的试点研究

Vickroy, Angela M; Kavanaugh, Margaret; Smith, Jordan; Wilson, Carmen A; Stockerl-Goldstein, Keith; Schroeder, Mark A; Vij, Ravi; Slade, Michael J; Fiala, Mark A

The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans

橙剂暴露与不明原因单克隆丙种球蛋白病进展为多发性骨髓瘤的关联:一项基于越南战争时期老兵人群的研究

Liu, Lawrence W; Wang, Mei; Grandhi, Nikhil; Schroeder, Mark A; Thomas, Theodore; Vargo, Kristin; Gao, Feng; Sanfilippo, Kristen M; Chang, Su-Hsin

An Injury-like Signature of the Extracellular Glioma Metabolome

细胞外胶质瘤代谢组的损伤样特征

Ha, Yooree; Rajani, Karishma; Riviere-Cazaux, Cecile; Rahman, Masum; Olson, Ian E; Gharibi Loron, Ali; Schroeder, Mark A; Rodriguez, Moses; Warrington, Arthur E; Burns, Terry C

A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

一项多中心 II 期临床试验,研究 10 天地西他滨、剂量递增的供体淋巴细胞输注和鲁索替尼治疗异基因造血干细胞移植后复发性急性髓系白血病和骨髓增生异常综合征的疗效

Rashidi, Armin; Huselton, Eric J; Stefanski, Heather E; DeFor, Todd E; Shanley, Ryan; Choi, Jaebok; DiPersio, John F; Juckett, Mark; Miller, Jeffrey S; Weisdorf, Daniel J; Schroeder, Mark A

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

匹配无关供者造血干细胞移植后早期应用阿扎胞苷的I/II期试验

Xu, Ziheng; Choi, Jaebok; Cooper, Matthew; King, Jeffrey; Fiala, Mark A; Liu, Jingxia; Pusic, Iskra; Romee, Rizwan; Cashen, Amanda; Jacoby, Meagan A; Stockerl-Goldstein, Keith; Abboud, Camille; Vij, Ravi; Uy, Geoffrey; Westervelt, Peter; Walter, Matthew J; DiPersio, John F; Schroeder, Mark A

A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612

一项针对60岁及以上新诊断急性髓系白血病(AML)、高危骨髓增生异常综合征(MDS)或慢性粒单核细胞白血病(CMML)患者的随机II/III期研究,比较了“新型疗法”与阿扎胞苷的疗效:阿扎胞苷联合纳武利尤单抗与阿扎胞苷的比较报告:SWOG S1612

Assouline, Sarit; Michaelis, Laura C; Othus, Megan; Hay, Annette E; Walter, Roland B; Jacoby, Meagan A; Schroeder, Mark A; Uy, Geoffrey L; Law, Lisa Y; Cheema, Faisal; Sweet, Kendra L; Asch, Adam S; Liu, Jijun Jane; Moseley, Anna B; Maher, Tracy; Kingsbury, Laura L; Fang, Min; Radich, Jerald; Little, Richard F; Erba, Harry P

The Association of Agent Orange (AO) Exposure with Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Progression: A Population-based Study of Vietnam War Era Veterans

橙剂暴露与意义未明的单克隆丙种球蛋白病(MGUS)进展为多发性骨髓瘤(MM)的关联:一项基于越南战争时期老兵的群体研究

Liu, Lawrence W; Wang, Mei; Grandhi, Nikhil; Schroeder, Mark A; Thomas, Theodore; Vargo, Kristin; Gao, Feng; Sanfilippo, Kristen M; Chang, Su-Hsin

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

系统性IL-15促进接受自然杀伤细胞过继疗法患者的同种异体细胞排斥反应

Berrien-Elliott, Melissa M; Becker-Hapak, Michelle; Cashen, Amanda F; Jacobs, Miriam; Wong, Pamela; Foster, Mark; McClain, Ethan; Desai, Sweta; Pence, Patrick; Cooley, Sarah; Brunstein, Claudio; Gao, Feng; Abboud, Camille N; Uy, Geoffrey L; Westervelt, Peter; Jacoby, Meagan A; Pusic, Iskra; Stockerl-Goldstein, Keith E; Schroeder, Mark A; DiPersio, John F; Soon-Shiong, Patrick; Miller, Jeffrey S; Fehniger, Todd A